Peptide Billing Code Reference for PE Healthcare Portfolios

Why Every PE Portfolio Needs a Peptide Billing Code Reference

A centralized billing code reference saves your team time and reduces costly errors. When every location in your PE portfolio uses the same reference, billing becomes consistent and predictable.

Without a shared reference, each location may code the same treatment differently. This creates inconsistencies in your data and increases the risk of denials and compliance problems.

Robert Tennant, Director of Health Information Technology Policy, Medical Group Management Association: "Consistency in medical coding across practice locations is the single biggest factor in reducing claim denials and improving revenue cycle performance"

How to Use This Peptide Billing Code Reference

This reference covers the most common codes used in peptide therapy billing. It is organized by code type so your team can quickly find the information they need.

Keep in mind that codes change regularly. Use this as a starting point and verify current codes through the AMA and CMS databases before applying them to live claims.

Over 30% of peptide therapy claims submitted with unclassified J-codes (J3490/J3590) are initially denied due to insufficient product documentation on the claim.

CPT Codes for Peptide Administration

CPT code 96372 covers therapeutic, prophylactic, or diagnostic injections given subcutaneously or intramuscularly. This is the most commonly used code for peptide therapy injections.

CPT codes 96365 through 96368 cover intravenous infusion services. Code 96365 is for the initial infusion of up to one hour, while 96366 covers each additional hour.

Additional Injection and Infusion Codes

Code 96369 covers subcutaneous infusion of up to one hour, which may apply to certain peptide delivery methods. Code 96370 covers each additional hour of subcutaneous infusion.

Code 96371 is an add-on code for additional subcutaneous infusion using a new substance or drug. These codes are less common but apply to specific peptide therapy protocols.

Drug Administration Codes

Code 96401 is for chemotherapy administration by subcutaneous or intramuscular injection. Some peptide therapies may fall under this code depending on the clinical context.

Code 96402 covers chemotherapy administration by other techniques. Always verify with the payer whether a specific peptide therapy qualifies for chemotherapy administration codes.

HCPCS Level II Codes for Peptide Products

HCPCS J-codes identify specific drugs and biologicals. For peptide therapies with assigned codes, use the specific J-code for the product administered.

Many peptide products do not have their own J-code yet. In these cases, use J3490 (unclassified drugs) or J3590 (unclassified biologics) with detailed product information in the claim.

Common Peptide-Related HCPCS Codes

J2941 covers somatropin injection, which is one of the most established peptide therapies. J1950 covers leuprolide acetate injection, another widely used peptide product.

J0897 covers denosumab injection, and J9217 covers leuprolide acetate for depot suspension. Each of these codes has specific dosage and administration requirements that must be followed.

Using Unclassified Drug Codes

When using J3490 or J3590, include the drug name, NDC number, dosage, and route of administration in the claim. Payers need this information to process the claim.

Some payers require a letter of medical necessity when unclassified codes are used. Build this requirement into your standard workflow to avoid delays and denials.

ICD-10 Diagnosis Codes for Peptide Therapy

ICD-10 codes describe the medical reason for the treatment. The diagnosis code must support the medical necessity of the peptide therapy.

Common diagnosis categories include endocrine disorders (E00-E89), immune system conditions (D80-D89), and musculoskeletal disorders (M00-M99). Use the most specific code available within each category.

Frequently Used ICD-10 Codes

E23.0 covers hypopituitarism, which is a common indication for growth hormone peptide therapy. E34.3 covers short stature not otherwise classified.

E66.01 covers morbid obesity due to excess calories, which may support certain peptide weight management therapies. E29.1 covers testicular hypofunction, another common indication.

When using J3490 or J3590 for peptide products without a specific HCPCS code, always include the drug name, NDC number, dosage, and route of administration in the claim's description field to minimize denial rates.

Modifier Codes for Peptide Therapy

Modifier 25 indicates a significant, separately identifiable evaluation and management service on the same day as a procedure. Use this when the office visit and the peptide injection are both billable.

Modifier 59 indicates a distinct procedural service, used to prevent inappropriate claim bundling. Apply this when two procedures that would normally be bundled were truly separate and distinct.

Additional Important Modifiers

Modifier 76 indicates a repeat procedure by the same physician on the same day. This applies when a patient receives multiple peptide injections during one visit.

Modifier JW indicates a discarded drug amount and is used when a portion of a single-use vial is not administered to the patient. This modifier helps you bill for the wasted portion of expensive peptide products.

Evaluation and Management Code Selection

E/M codes for outpatient visits range from 99202 to 99215. The level selected must match the complexity of the medical decision-making documented in the visit notes.

For new patient visits, use codes 99202 through 99205. For established patient visits, use codes 99211 through 99215. For additional context, the CMS HCPCS coding resources offers relevant guidance on this topic.

Place of Service Codes

Place of service (POS) codes tell the payer where the treatment was provided. POS 11 is for office visits, POS 22 is for outpatient hospital, and POS 49 is for independent clinic.

Using the wrong POS code can lead to denials or payment at a lower rate. Make sure your team selects the POS code that matches where the service actually took place.

Building Your Portfolio-Wide Code Reference

Create a master spreadsheet or database that lists every peptide treatment your portfolio offers. For each treatment, include the corresponding CPT, HCPCS, ICD-10, and modifier codes.

Assign ownership of the reference to a specific team member who is responsible for keeping it current. Distribute updates to all locations whenever codes change.

Code Mapping for Common Peptide Treatments

For BPC-157 injections, the typical code set includes 96372 (injection), J3490 (unclassified drug), and the appropriate ICD-10 and E/M codes. For GHK-Cu, a similar code set applies with J3490.

For FDA-approved peptides like semaglutide, use the specific HCPCS code assigned to that product. Always check for product-specific codes before defaulting to unclassified codes.

Payer-Specific Code Variations

Some payers require specific code combinations or additional codes for peptide therapy. Medicare, for example, may have different coverage rules than commercial payers.

Document any payer-specific coding requirements in your reference. This prevents your team from using the wrong codes for a given payer and reduces denials.

Keeping Your Code Reference Current

Set a quarterly review schedule to update your code reference. Check for new HCPCS codes from CMS, CPT changes from the AMA, and ICD-10 updates.

Subscribe to coding newsletters and join professional organizations like AAPC for timely updates. Assign one person to monitor changes and communicate them to the team.

Training Your Team on the Code Reference

Every biller and coder should know how to use the code reference. Walk through it during onboarding and review it in monthly team meetings.

Use case studies from real claims to show how the reference applies to daily work. Test your team's knowledge periodically with coding quizzes and scenarios.

Standardizing your billing code reference across every portfolio location eliminates coding inconsistencies that directly cause claim denials and compliance risk.

Frequently Asked Questions

What is the most common CPT code for peptide therapy injections?

CPT code 96372 is the most commonly used code for peptide therapy injections given subcutaneously or intramuscularly. For IV infusions, use codes 96365 through 96368 based on duration and number of substances.

What HCPCS code should we use for compounded peptides?

Most compounded peptides use J3490 (unclassified drugs) or J3590 (unclassified biologics) because they do not have specific assigned codes. Include the drug name, NDC number, dosage, and route of administration with the claim.

How often do peptide billing codes change?

CPT codes are updated annually by the AMA, with changes effective January 1. HCPCS Level II codes are updated quarterly by CMS. ICD-10 codes are updated annually on October 1.

What modifiers are most important for peptide therapy billing?

Modifier 25 (significant E/M service), Modifier 59 (distinct procedural service), and Modifier JW (drug waste) are the most important for peptide therapy billing. Using the right modifiers prevents bundling denials and recovers revenue from discarded drug amounts.

Should every location in our PE portfolio use the same code reference?

Yes, a standardized code reference across all locations ensures billing consistency, reduces errors, and makes it easier to compare performance across sites. Centralize the reference and distribute updates to all locations simultaneously.

Get Expert Coders with PeptideStaff

Accurate coding starts with skilled professionals. PeptideStaff places certified coders and billers who know peptide therapy codes and understand the demands of PE-backed healthcare portfolios.

Contact PeptideStaff today to find the coding talent your portfolio needs. We help you build a team that gets every code right, every time.